1. Home
  2. |Insights
  3. |DEAL NOTE: Crowell & Moring Represents Kountable in Series A-1 Financing Lead by Lateral Capital

DEAL NOTE: Crowell & Moring Represents Kountable in Series A-1 Financing Lead by Lateral Capital

Firm News | 1 min read | 02.10.21

San Francisco – February 10, 2021: Crowell & Moring advised Kountable Inc., the leading global trade and technology platform, in connection with its Series A-1 financing lead by Lateral Capital. Kountable secured this round of funding as part of its efforts to expand its U.S. presence and widen its COVID response to further support small and medium-sized enterprises (SMEs). The Kountable platform operates as the necessary missing element that gets critical goods delivered in difficult market conditions. For the past five years, Kountable has activated the capability of SMEs through is curated execution network to efficiently complete large scale projects for governments, foundations, NGOs, and corporations that have had a positive impact on millions of lives. Kountable has solved the challenges of collaboration between critical but overlooked SMEs who play a key role in the success of vast swaths of global trade activity, global multinational suppliers, funders, and logistics and trade services providers.

Kountable will use the strategic capital to scale its business in global healthcare supply chains, specifically in connection with the pandemic response. The funding investment will further enhance its trade and treasury cloud platform, as well as launch its long-anticipated membership offering within the U.S. that will particularly focus on supplier diversity programs and inclusive supply chains. Kountable’s current presence includes offices in San Francisco, Nairobi, Kigali, and The Hague.

Crowell & Moring served as lead counsel to Kountable in this transaction. The team included partners Jon O'Connell and Olivia Lynch, senior counsels Mark Kass and Scott Lessne, and counsel Steven Ryan.

Insights

Firm News | 1 min read | 03.11.25

Crowell & Moring Represents Nuclear Energy Startup Atomic Alchemy in its Acquisition by Oklo

March 11, 2025: Oklo Inc. (NYSE: OKLO), an advanced nuclear technology company, announced on March 5, 2025 that it has closed the $25 million acquisition of Crowell client Atomic Alchemy Inc. (“Atomic Alchemy”), a leading innovator in radioisotope production. Oklo intends to use this strategic acquisition to establish a more reliable domestic supply chain for high-value radioisotopes critical to healthcare, research, and defense sectors and provides synergies to Oklo’s fuel recycling and nuclear energy businesses. Demand for radioisotopes is expected to increase significantly over the next decade, while global supply struggles to keep pace due to aging reactor infrastructure and a fragmented global supply chain, which at present is dominated by countries outside the United States. Atomic Alchemy intends to be a low-cost U.S. radioisotope producer that can provide a secure and domestic supply of radioisotopes to U.S. companies commercializing innovative radioisotope applications. With its proprietary VIPR® technology, Atomic Alchemy is building the first scalable production facility to provide a reliable, sustainable source of high-value radioisotopes. Using a vertically integrated model and fuel recycling, in partnership with Oklo, Atomic Alchemy is transforming isotope production to address global shortages, support critical applications, and strengthen national security. The core deal team included Samuel Holland Edwards, Jon O’Connell, Justin Lurie, and Ryan Flynn....

View All Insights